Octoplus

OctoPlus is a Dutch biotechnology company specializing in the development of advanced drug delivery systems and providing specialized contract manufacturing services. The company is recognized for its proprietary PolyActive and OctoDEX platforms, which facilitate the controlled and sustained release of proteins, peptides, and small molecules. As a service provider, OctoPlus offers formulation development and clinical trial material manufacturing under GMP conditions. In 2013, the company was acquired by Dr. Reddy's Laboratories to enhance its capabilities in complex injectable products. Its internal pipeline historically featured Locteron, a controlled-release interferon alpha-2b for Hepatitis C, developed in partnership with Biolex Therapeutics.